Bixlenvo Tablet, Film Coated
Product Images NDC 61958-3601

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bixlenvo (NDC 61958-3601). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Bictegravir Structure)

Chemical structure of bictegravir, one of the active ingredients in BIXLENVO tablets. The structure includes multiple rings, fluorine atoms, and functional groups characteristic of the molecule.*

FDA Label Image

Bixlenvo-01 (Bixlenvo 01)

Bixlenvo 75 mg/50 mg tablets packaging label showing the product name, active ingredients bictegravir and lenacapavir, strength, quantity of 30 tablets, and manufacturer Gilead Sciences, Inc. The label includes storage instructions, dosage form as film-coated tablets for oral use, and the product NDC 61958-3601-1.*

FDA Label Image

Chemical Structure (Lenacapavir Structure)

Chemical structure diagram of the active ingredient bictegravir from the drug product BIXLENVO. The diagram shows the molecular arrangement with labeled atoms, including fluorine, chlorine, nitrogen, sulfur, oxygen, carbon, hydrogen (implied), sodium ion, and methyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.